Functional genomic characterization of the USP1 inhibitor KSQ-4279 reveals a distinct mechanism of action and resistance profile relative to other DDR targeting drugs.

Shenker, S; Gannon, H; Carlson, A; Grasberger, P; Sullivan, P; Middleton, C; Dodson, A; Bullock, C; McGuire, M; Tobin, E; Sinkevicius, K; Schlabach, M; Stegmeier, F; Cadzow, L; Wylie, A

CANCER RESEARCH, 2021; 81 (13):